A carregar...
RAS testing in metastatic colorectal cancer: advances in Europe
Personalized medicine shows promise for maximizing efficacy and minimizing toxicity of anti-cancer treatment. KRAS exon 2 mutations are predictive of resistance to epidermal growth factor receptor-directed monoclonal antibodies in patients with metastatic colorectal cancer. Recent studies have shown...
Na minha lista:
| Publicado no: | Virchows Arch |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4830882/ https://ncbi.nlm.nih.gov/pubmed/26573425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00428-015-1876-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|